| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 246.81B | 232.98B | 233.41B | 233.87B | 196.58B | 198.96B |
| Gross Profit | 80.37B | 76.18B | 73.52B | 68.19B | 60.08B | 55.94B |
| EBITDA | 42.20B | 43.19B | 39.87B | 36.22B | 31.24B | 28.25B |
| Net Income | 23.89B | 24.27B | 22.09B | 20.22B | 16.77B | 15.60B |
Balance Sheet | ||||||
| Total Assets | 341.27B | 333.65B | 324.11B | 293.10B | 273.29B | 259.04B |
| Cash, Cash Equivalents and Short-Term Investments | 87.09B | 99.08B | 94.04B | 85.22B | 74.39B | 72.65B |
| Total Debt | 69.39B | 69.65B | 73.43B | 65.65B | 74.78B | 69.76B |
| Total Liabilities | 151.59B | 155.40B | 158.79B | 148.02B | 145.61B | 137.07B |
| Stockholders Equity | 185.94B | 174.75B | 162.16B | 142.52B | 126.06B | 120.59B |
Cash Flow | ||||||
| Free Cash Flow | 3.42B | 18.51B | 9.71B | 25.13B | 8.13B | 18.43B |
| Operating Cash Flow | 11.83B | 25.91B | 25.73B | 34.15B | 24.95B | 27.25B |
| Investing Cash Flow | -10.72B | -8.77B | -20.77B | -10.70B | -17.82B | -10.36B |
| Financing Cash Flow | -16.63B | -15.28B | 3.03B | -12.95B | -5.96B | -4.87B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥977.91B | 25.41 | 11.06% | 2.88% | 11.00% | 88.70% | |
75 Outperform | ¥241.58B | 8.22 | ― | 2.67% | 2.29% | -4.12% | |
72 Outperform | ¥1.13T | 9.44 | 19.60% | 1.94% | 3.13% | 11.87% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
64 Neutral | ¥144.98B | 10.72 | 14.78% | 2.95% | 17.74% | 19.41% | |
63 Neutral | ¥157.89B | 20.44 | 8.95% | 3.39% | 28.94% | 109.35% | |
57 Neutral | ¥46.37B | -26.35 | ― | 3.75% | -8.66% | -53.57% |